Huntington National Bank’s MEDICIS PHARMACEUTICAL CL-A MRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $44 | Hold |
1
| – | – | ﹤0.01% | 2994 |
|
|
2025
Q4 | $44 | Hold |
1
| – | – | ﹤0.01% | 2913 |
|
|
2025
Q3 | $44 | Hold |
1
| – | – | ﹤0.01% | 2981 |
|
|
2025
Q2 | $44 | Hold |
1
| – | – | ﹤0.01% | 3008 |
|
|
2025
Q1 | $44 | Hold |
1
| – | – | ﹤0.01% | 3038 |
|
|
2024
Q4 | $44 | Hold |
1
| – | – | ﹤0.01% | 3062 |
|
|
2024
Q3 | $44 | Hold |
1
| – | – | ﹤0.01% | 3064 |
|
|
2024
Q2 | $44 | Hold |
1
| – | – | ﹤0.01% | 3018 |
|
|
2024
Q1 | $44 | Hold |
1
| – | – | ﹤0.01% | 2863 |
|
|
2023
Q4 | $44 | Hold |
1
| – | – | ﹤0.01% | 2767 |
|
|
2023
Q3 | $44 | Hold |
1
| – | – | ﹤0.01% | 2743 |
|
|
2023
Q2 | $44 | Hold |
1
| – | – | ﹤0.01% | 2713 |
|
|
2023
Q1 | $44 | Hold |
1
| – | – | ﹤0.01% | 2560 |
|
|
2022
Q4 | $44 | Hold |
1
| – | – | ﹤0.01% | 2420 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2816 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2818 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2745 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2671 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2397 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2286 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2175 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2153 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2100 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2113 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2208 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2219 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2125 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2159 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 2156 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2211 |
|
|
2018
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2198 |
|
Huntington National Bank's MRX Position: Q1 2026 in Review
Huntington National Bank held its MEDICIS PHARMACEUTICAL CL-A (MRX) position steady in Q1 2026 at 1 share worth $44. The position accounts for ﹤0.01% of the portfolio, ranked #2994.
Huntington National Bank first reported a position in MRX in Q3 2018 and has held it in 30 quarters since. 1 fund tracked by Wall St. Rank holds MRX as of Q1 2026.
- Huntington National Bank held 1 share of MEDICIS PHARMACEUTICAL CL-A worth $44 as of Q1 2026.
- Huntington National Bank left its MEDICIS PHARMACEUTICAL CL-A share count unchanged in Q1 2026.
- MEDICIS PHARMACEUTICAL CL-A made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2994 holding.
- Huntington National Bank first reported a position in MEDICIS PHARMACEUTICAL CL-A in Q3 2018 and has held it in 30 quarters since.
- 1 fund tracked by Wall St. Rank held MEDICIS PHARMACEUTICAL CL-A as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.